Stock listing
Adhera Therapeutics Inc.
Selected listing: ATRX · OTC · USD · US
Adhera Therapeutics Inc. (OTC:ATRX), Health Technology. Latest release Jan 25, 2023: Adhera Therapeutics to Collaborate with Alberta Diabetes Institute…
- Ticker
- OTC:ATRX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Adhera Therapeutics Inc.
The company focuses on developing innovative therapeutics aimed at improving patient outcomes. Adhera is committed to advancing its pipeline of treatments to address unmet medical needs.
Latest news from Adhera Therapeutics Inc.
Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes
January 25, 2023
Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist
September 19, 2022
Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin
July 19, 2022
Adhera Therapeutics Appoints Trond K. Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ
May 19, 2022
Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board
March 21, 2022
Research Adhera Therapeutics Inc.
Adhera Therapeutics Inc. company profile
View the public company page for Adhera Therapeutics Inc. on 6ix.
Adhera Therapeutics Inc. news
Read company news and market updates connected to Adhera Therapeutics Inc..
Adhera Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Adhera Therapeutics Inc..